2016
DOI: 10.1016/j.xphs.2016.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Development and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells

Abstract: This study aimed to develop a curcumin (CM) nanoparticle targeted to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 (FLT3) protein on the surface of leukemic cells and to evaluate their properties, specificity, cytotoxicity, and inhibitory effect on FLT3 protein level in FLT3 overexpressing leukemic cells, EoL-1 and MV-4-11 cells. FLT3-specific peptides were conjugated onto modified poloxamer 407 (P407) using the copper-catalyzed azide-alkyne cycloaddition reaction (CuAAC). The thin film hydration metho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 54 publications
0
13
0
Order By: Relevance
“…It is mostly found to overexpress on the cell surface of AML leukemic stem cells and leukemic cells and plays an important role in cell survival and proliferation of leukemic cell blasts 33 . Cur has previously been shown to have an inhibitory effect on FLT3 protein expression in many types of FLT-3 expressing leukemic cell lines, such as EoL-1 and MV4-11 27 . Thus, it was selected as a target protein for Dox-Cur treatment.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…It is mostly found to overexpress on the cell surface of AML leukemic stem cells and leukemic cells and plays an important role in cell survival and proliferation of leukemic cell blasts 33 . Cur has previously been shown to have an inhibitory effect on FLT3 protein expression in many types of FLT-3 expressing leukemic cell lines, such as EoL-1 and MV4-11 27 . Thus, it was selected as a target protein for Dox-Cur treatment.…”
Section: Resultsmentioning
confidence: 99%
“…FLT3 is a key driver of AML, and its mutations are associated with the development of high risk of relapse in patients. Previous studies demonstrated that Cur has an inhibitory effect on FLT3 protein expression in leukemic cells 27 . Thus, the combination of Dox and Cur for AML treatment may lead to FLT3 protein expression reduction, which is involved in the proliferation process of leukemic cells.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…FLT3 specific peptide with poloxamer formed micelle containing curcumin. In vitro studies using flow cytometry and fluorescence microscopy showed that FLT3-curcumin killed leukaemic cells by enriched internalization [104]. Further studies in detail about the mechanism can quickly transform curcumin from benchside to bedside and clinical applications since it has an impressive performance against various diseases including cancers.…”
Section: Anticancer Property Of Encapsulated Curcuminmentioning
confidence: 99%
“…Curcumin have inhibiting effects on it, FLT3 interruption, and development of cell cycle (Figure 5).Curcumin loaded miceSlle formation has been used to inhibit formation cancerous cells[57]. Many FLT3 inhibitors such as PKC412, AC220, CEP-701, and AR200 have been used to overcome the levels of phosphorylated FLT3 protein.Significant decline was detected in cellular level of FLT3 protein after curcuminoid treatment as it arrested the activity of cell cycle at the G0/G1 phase and decreased the FLT3 and STAT protein levels[65]. Effects of curcumin on different S.Rafiq et al…”
mentioning
confidence: 99%